MPM BioImpact LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$6,841,507
+7.8%
664,224
+72.5%
1.83%
+42.9%
Q2 2023$6,344,635
+207.1%
384,990
-6.6%
1.28%
+161.3%
Q3 2022$2,066,000
+105.4%
412,3630.0%0.49%
+75.3%
Q2 2022$1,006,000
-64.3%
412,3630.0%0.28%
-63.1%
Q1 2022$2,816,000
-7.2%
412,363
+9.9%
0.76%
+36.7%
Q4 2021$3,033,000
-22.6%
375,326
-6.2%
0.55%
-9.0%
Q3 2021$3,920,000400,0000.61%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders